Oorsprong van het eerstegraads netwerk van Anthony R DePasqua
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Enclear Therapies, Inc.
Enclear Therapies, Inc. Pharmaceuticals: MajorHealth Technology Enclear Therapies, Inc. develops and manufactures novel device-based therapies to treat patients. The firm device is developed to treat and halt the progression of neurodegenerative diseases by removing toxic proteins known to drive pathology. The company was founded by Anthony R. DePasqua, Jonathan J. Fleming, Kasper Roet, William B. Gormley and Kevin Eggan and is headquartered in Newburyport, MA.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Anthony R DePasqua via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
20/20 HealthCare Partners LLC
20/20 HealthCare Partners LLC Investment ManagersFinance 20/20 HealthCare Partners LLC (20/20 HealthCare Partners) is a venture capital firm founded in 2005 by Hillel Bachrach. The firm is headquartered in Auburndale, Massachusetts. | Investment Managers | Consultant / Advisor Founder Consultant / Advisor | |
Nemdx, Inc.
Nemdx, Inc. Packaged SoftwareTechnology Services Nemdx, Inc. is a medical diagnostic platform that focuses on revealing critical information on protein function in neurodegenerative diseases. | Packaged Software | Director/Board Member Director/Board Member | |
QurAlis Corp.
QurAlis Corp. Pharmaceuticals: MajorHealth Technology QurAlis Corp. engages in discovering and developing new therapies for amyotrophic lateral sclerosis and other neurological diseases. It offers therapeutic programs and targets, and biomarkers. The company was founded by Clifford Woolf, Kevin Eggan, Jonathan J. Fleming, and Kasper Roet and is headquartered in North Cambridge, MA. | Pharmaceuticals: Major | Founder Founder | |
Weizmann Institute of Science | College/University | Doctorate Degree | |
Eloxx Pharmaceuticals Ltd.
Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
Microbion Corp.
Microbion Corp. Pharmaceuticals: MajorHealth Technology Microbion Corp. develops topical microbial therapeutic products. It safeguards human health by overcoming infections, antibiotic resistance, and microbial biofilms with safe, effective anti-infective products. The firm is developing MBN-101 as the first product in a new class for the treatment of antibiotic-resistant and difficult to treat infections. The company was founded by Brett H. Baker and is headquartered in Bozeman, MT. | Pharmaceuticals: Major | Director/Board Member | |
PhysIQ, Inc.
PhysIQ, Inc. Packaged SoftwareTechnology Services PhysIQ, Inc. provides proprietary predictive analytics for human physiology. It designs, develops and commercializes predictive analytics technologies to monitor the health of complex systems. The company was founded by Matt R. Pipke and Gary W. Conkright in 1999 and is headquartered in Naperville, IL. | Packaged Software | Director/Board Member | |
Lyndra Therapeutics, Inc.
Lyndra Therapeutics, Inc. Packaged SoftwareTechnology Services Lyndra Therapeutics, Inc. develops software technology for oral drug formulations. It offers pharmacology, therapeutic impact, reduced pill burden, and reduced care giver burden. The company was founded by Amy W. Schulman, Carlo Giovanni Traverso, Andrew Bellinger, and Robert S. Langer Jr. in 2015 and is headquartered in Watertown, MA. | Packaged Software | Director/Board Member | |
Oxford Bioscience Partners
Oxford Bioscience Partners Investment ManagersFinance Oxford Bioscience Partners is an Independent Venture Capital firm founded in 1992 by Edmund Martin Olivier, Alan G. Walton and Cornelius T. Ryan. The firm is headquartered in Boston. | Investment Managers | Private Equity Investor | |
KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Xrhealth, Inc.
Xrhealth, Inc. Internet Software/ServicesTechnology Services Xrhealth, Inc. is a healthcare company that utilizes spatial computing to revolutionize the industry. Xrhealth is based in Boston, MA, and its R&D center is located in Israel. The company operates virtual rooms that use proprietary FDA and CE registered medical extended reality (XR) technology, including virtual and augmented reality. Xrhealth integrates immersive XR technology, licensed clinicians, and advanced data analytics on one platform, providing a comprehensive therapeutic care solution for patients to receive treatment from the comfort of their home. The company offers a variety of patent-pending solutions from rehabilitation services to cognitive assessment and training to pain management. Xrhealth works with several world-renowned healthcare providers, hospitals, and rehabilitation centers. The company was founded by Michael Levy and Eran Orr, with Eran Orr serving as CEO since incorporation. | Internet Software/Services | Director/Board Member | |
Zixi LLC
Zixi LLC Packaged SoftwareTechnology Services Zixi LLC engages in the provision of content delivery at satellite and fiber operating metrics with internet based economic solutions. It operates in the following segments: Broadcast Media, sports and live events, house if worship, and over the top. The firm’s solutions include contribution, distribution, processing, and mobile content. The company was founded by Israel Drori and Uri Avni in 2006 and is headquartered in Waltham, MA. | Packaged Software | Director/Board Member | |
SRS Medical Systems, Inc.
SRS Medical Systems, Inc. Medical SpecialtiesHealth Technology SRS Medical Systems, Inc. manufactures medical devices for the diagnosis and conservative treatment of incontinence. Its products include The Spanner and The UroCuff Test. The company was founded by Kevin M. Connolly and John Reid in 1991 and is headquartered in North Billerica, MA. | Medical Specialties | Director/Board Member | |
LUMENIS LTD | Medical Specialties | Director/Board Member | |
OREX Computed Radiography Ltd.
OREX Computed Radiography Ltd. Electronic Equipment/InstrumentsElectronic Technology OREX Computed Radiography Ltd. is an Israeli company that provides computed radiography system services. The company is based in Yokneam, Israel and was founded in 1995. | Electronic Equipment/Instruments | Chief Executive Officer | |
CORINDUS VASCULAR ROBOTICS INC | Medical Specialties | Director/Board Member | |
SQZ BIOTECHNOLOGIES COMPANY | Biotechnology | Director/Board Member | |
CathWorks Ltd.
CathWorks Ltd. Medical SpecialtiesHealth Technology CathWorks Ltd. develops medical devices for the interventional cardiology market. Its technology is based on processing visual information and automatic multi-layered algorithms. The company was founded by Guy Lavi and Ifat Lavi in 2013 and is headquartered in Raanana, Israel. | Medical Specialties | Director/Board Member | |
20/20 Capital III LLC | Director/Board Member | ||
ATAI Life Sciences AG
ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Marist College | College/University | Undergraduate Degree | |
Amgen Ventures LLC
Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Private Equity Investor | |
Thiel Capital LLC
Thiel Capital LLC Investment ManagersFinance Thiel Capital LLC (Thiel Capital) is a venture capital firm founded in 2011 by Peter Andreas Thiel. The firm is headquartered in West Hollywood, California. | Investment Managers | Director/Board Member | |
Alloy Therapeutics LLC
Alloy Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Friedman School of Nutrition Science & Policy | College/University | Director/Board Member | |
ATAI LIFE SCIENCES N.V. | Pharmaceuticals: Major | Director/Board Member | |
Chemomab Ltd.
Chemomab Ltd. BiotechnologyHealth Technology ChemomAb Ltd. develops novel chemokine blocking therapies for inflammatory and fibrotic disorders. It specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of immune-mediated and fibrotic disorders including orphan indications. The company was founded by Adi Mor and Jacob George in 2011 and is headquartered Tel Aviv, Israel. | Biotechnology | Director/Board Member | |
COMPASS PATHWAYS PLC | Biotechnology | Director/Board Member | |
The University College of Osteopathy | College/University | Graduate Degree | |
The Thiel Foundation
The Thiel Foundation Investment Trusts/Mutual FundsMiscellaneous The Thiel Foundation awards grants to groups that empower people to improve their lives, champions organizations and individuals who expose human rights abuses and authoritarianism. It programs include The Thiel Fellowship, Breakout Labs and Imitatio. The company is headquartered in San Francisco, CA. | Investment Trusts/Mutual Funds | Director/Board Member | |
Invicta Medical, Inc.
Invicta Medical, Inc. Medical SpecialtiesHealth Technology Invicta Medical, Inc. operates as a medical technology company that develops wearable device for treatment of sleep apnea and snoring. Its device detects and treats disturbed breathing through electrical stimulation. The company was founded by Steven T. Kent and Harold Kent in 2013 and is headquartered in Portola Valley, CA. | Medical Specialties | Director/Board Member | |
Quark Venture, Inc.
Quark Venture, Inc. Investment ManagersFinance Quark Venture Inc (Quark) is a venture capital investment firm founded in 2015 and headquartered in Vancouver, Canada. | Investment Managers | Private Equity Investor | |
Ben-Gurion University of the Negev | College/University | Graduate Degree | |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Raziel Therapeutics RT Ltd.
Raziel Therapeutics RT Ltd. Pharmaceuticals: MajorHealth Technology Raziel Therapeutics RT Ltd. develops innovative technology to treat obesity disease. It is developing RZL-12, is a potential first-in-class, injectable drug for the reduction of fat cell mass. the firm developed a novel drug (NCE) that after a single injection into subcutaneous fat, converts white adipose tissue (WAT) into brown adipose tissue-like. The company was founded by Shmuel A. Ben-Sasson in 2012 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kellogg School of Management | College/University | Masters Business Admin | |
New England Healthcare Institute
New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services New England Healthcare Institute operates as a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. The company was founded by Henri A. Termeer in 2002 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Avaxia Biologics, Inc.
Avaxia Biologics, Inc. BiotechnologyHealth Technology Avaxia Biologics, Inc. operated as a clinical-stage biotechnology company. It engaged in the development of gut-targeted antibody therapeutics for gastroenterology indications. Gut-targeted antibody therapeutics is orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal (GI) tract including the mouth, throat, and intestines. The company was founded by David Poorvin and Barbara S. Fox in 2005 and was headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
Leerink Swann Investment Trust | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 35 |
Israël | 11 |
Duitsland | 3 |
Verenigd Koninkrijk | 3 |
Canada | 2 |
Sectoraal
Health Technology | 27 |
Technology Services | 7 |
Consumer Services | 7 |
Finance | 6 |
Commercial Services | 3 |
Operationeel
Director/Board Member | 62 |
Chairman | 10 |
Founder | 9 |
Corporate Officer/Principal | 7 |
Independent Dir/Board Member | 6 |
Sterkste connecties
Insiders | |
---|---|
Jonathan Fleming | 36 |
Hillel Bachrach | 23 |
Zafrira Avnur | 20 |
Jason Camm | 11 |
Gladys Nunez | 4 |
Kasper Roet | 2 |
William B. Gormley | 1 |
Laura Paulsen | 1 |
- Beurs
- Insiders
- Anthony R DePasqua
- Bedrijfsconnecties